Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathryn Gaebel

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 12, 2011
Measuring health-related quality-of-life for Alzheimer's disease using the general publicFeng Xie, Mark Oremus, Kathryn Gaebel
Plos One|September 3, 2016
Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative StudyMark Oremus, Feng Xie, Kathryn Gaebel
BMC Geriatrics|February 5, 2016
Can the general public use vignettes to discriminate between Alzheimer's disease health states?Mark Oremus, Feng Xie, Eleanor Pullenayegum, et al.
Drugs & Aging|February 20, 2013
Cost-effectiveness of pharmaceutical management for osteoarthritis pain: a systematic review of the literature and recommendations for future economic evaluationFeng Xie, Pimwara Tanvejsilp, Kaitryn Campbell, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 10, 2005
Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritisPendar Farahani, Mitchell Levine, Kathryn Gaebel, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 26, 2013
Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklistFeng Xie, Kathryn Gaebel, Kuhan Perampaladas, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 26, 2014
Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?Eleanor M Pullenayegum, Kuhan Perampaladas, Kathryn Gaebel, et al.
International Journal of Circumpolar Health|September 20, 2011
Health economic evaluations help inform payers of the best use of scarce health care resourcesDaria O'Reilly, Kathryn Gaebel, Feng Xie, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 29, 2015
How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuationsFatima Al Sayah, Ana Mladenovic, Kathryn Gaebel, et al.
Cost Effectiveness and Resource Allocation : C/E|December 17, 2009
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitisFeng Xie, Gord Blackhouse, Nazila Assasi, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 12, 2011
Measuring health-related quality-of-life for Alzheimer's disease using the general publicFeng Xie, Mark Oremus, Kathryn Gaebel
Plos One|September 3, 2016
Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative StudyMark Oremus, Feng Xie, Kathryn Gaebel
BMC Geriatrics|February 5, 2016
Can the general public use vignettes to discriminate between Alzheimer's disease health states?Mark Oremus, Feng Xie, Eleanor Pullenayegum, et al.
Drugs & Aging|February 20, 2013
Cost-effectiveness of pharmaceutical management for osteoarthritis pain: a systematic review of the literature and recommendations for future economic evaluationFeng Xie, Pimwara Tanvejsilp, Kaitryn Campbell, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 10, 2005
Clinical data gap between phase III clinical trials (pre-marketing) and phase IV (post-marketing) studies: evaluation of etanercept in rheumatoid arthritisPendar Farahani, Mitchell Levine, Kathryn Gaebel, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 26, 2013
Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklistFeng Xie, Kathryn Gaebel, Kuhan Perampaladas, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 26, 2014
Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?Eleanor M Pullenayegum, Kuhan Perampaladas, Kathryn Gaebel, et al.
International Journal of Circumpolar Health|September 20, 2011
Health economic evaluations help inform payers of the best use of scarce health care resourcesDaria O'Reilly, Kathryn Gaebel, Feng Xie, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 29, 2015
How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuationsFatima Al Sayah, Ana Mladenovic, Kathryn Gaebel, et al.
Cost Effectiveness and Resource Allocation : C/E|December 17, 2009
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitisFeng Xie, Gord Blackhouse, Nazila Assasi, et al.
Pageof 3